Journals / Anadolu Kardiyoloji Dergisi / 2004 / Cilt: 4 - Sayı: 4

Kalp cerrahisinde kullanılan enalaprilat infüzyonunun hemodinamik değişkenlere ve böbrek fonksiyonlarına etkisi

Effects of enalaprilat infusion on hemodynamics and renal function in patients undergoing cardiac surgery

Pages
296–300
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: In the control group postoperative blood creatinine and urea levels were significantly higher and CLcr measurements were significantly lower than the preoperative values (p0.05), but SVR was lower (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study was undertaken to evaluate the effect of Enalaprilat infusion on hemodynamics and renal function during cardiopulmonary bypass (CPB).Methods: Thirty adults undergoing CPB were randomly allocated into 2 groups.
📊
Key Findings & Data:All patients received the same anesthetic protocol and same dopamine infusion protocol (2 mg/kg -1/min-1) during the study.
💡
Conclusion & Impact:Results: In the control group postoperative blood creatinine and urea levels were significantly higher and CLcr measurements were significantly lower than the preoperative values (p0.05), but SVR was lower (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study was undertaken to evaluate the effect of Enalaprilat infusion on hemodynamics and renal function during cardiopulmonary bypass (CPB).Methods: Thirty adults undergoing CPB were randomly allocated into 2 groups. All patients received the same anesthetic protocol and same dopamine infusion protocol (2 mg/kg -1/min-1) during the study. In addition to dopamine infusion 15 patients received enalaprilat infusion (0.06 mg/kg-1/hr-1) during CPB. Blood creatinine, urea levels, and creatinine clearance (CLcr) were measured and cardiac output (CO) was calculated by echocardiography preoperatively and on the 6th postoperative day. Mean arterial pressure (MAP), central venous pressure (CVP), systemic vascular resistance (SVR) measurements were recorded during the operation and during postoperative 24 hours. Results: In the control group postoperative blood creatinine and urea levels were significantly higher and CLcr measurements were significantly lower than the preoperative values (p0.05), but SVR was lower (p

Özet

Amaç: Kardiyopulmoner baypas (KPB) sırasında kullanılan enalaprilat infüzyonunun hemodinamik değişkenlere ve böbrek fonksiyonlarına etkisini araştırmak.Yöntemler: Kardiyopulmoner baypas yapılacak 30 erişkin hasta rastgele olarak iki gruba ayrıldı. Tüm hastalarda standart anestezi yöntemi ve çalışma süresince dopamin infüzyonu kullanıldı (2 mg/kg–1/dak-1). Birinci grup hastalara (n=15) KPB sırasında enalaprilat infüzyonu (0.06 mg/kg-1/st-1) uygulandı. Preoperatif dönemde ve postoperatif 6. günde serum kreatinin ve üre düzeyleri ile kreatinin klirensleri (KLkr) ölçüldü ve ekokardiyografi ile kalp debileri hesaplandı. Ameliyat sırasında ve postoperatif 24 saat boyunca ölçülen ortalama arter basıncı (OAB), santral venöz basınç (SVB) ve sistemik vasküler rezistans (SVR) değerleri kaydedildi. Bulgular: Kontrol grubunun postoperatif dönemdeki kreatinin ve üre düzeyleri preoperatif döneme kıyasla anlamlı olarak yüksek, KLkr ölçümleri ise anlamlı olarak düşük bulundu (p0.05) enalaprilat grubunun SVR ölçümleri kontrol grubuna kıyasla anlamlı olarak düşük (p

🔖

Cite This Article

ZEYNELOĞLU, P., SEZGİN, A., TÜRKER, H., DÖNMEZ, A., ULUÇAM, M. (2022). Kalp cerrahisinde kullanılan enalaprilat infüzyonunun hemodinamik değişkenlere ve böbrek fonksiyonlarına etkisi. Anadolu Kardiyoloji Dergisi, Cilt: 4 - Sayı: 4, 296–300. https://ajindex.com/articles/437451

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Mangano CM, Hill L, Cartwright CR, Hindman B. Cardiopulmonary bypass and the anesthesiologist. In: Kaplan JA, editor. Cardiac Anesthesia. Philadelphia: WB Saunders; 1999. p.1061-110
  2. Colson P, Ribstein J, Mimran A, Grolleau D, Chaptal PA, Roquefeuil B. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology 1990;72:23-7
  3. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992 8;304:339-43
  4. Boldt J, Schindler KF, Stertman WA, Hempelmann G. Isolated circulatory response to intravenous administration of the ACE inhibitor enalaprilat. Br J Clin Pharmac 1994;37:341-6
  5. Ryckwaert F, Colson P, Ribstein J, Boccara G, Guillon G. Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 2001;86:169-75
  6. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67
  7. Quinones MA, Otto CM, Stoddard M, et al. Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 2002;15:167-84
  8. Rady MY, Ryan T. The effects of preoperative therapy with angiotensin converting enzyme inhibitors on clinical outcome after cardiovascular surgery. Chest 1998;114:487-94
  9. Bellomo R, Kellum J, Ronco C. Acute renal failure: time for consensus. Intensive Care Med 2001;27:1685-8
  10. Ryckwaert F, Boccara G, Frappier JM, Colson PH. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med 2002;30:1495-8
  11. Mulec H, Johnsen SA, Bjorck S. Long-term enalapril treatment in diabetic nephropathy. Kidney Int Suppl 1994;45:S141-4
  12. Gottlieb SS, Weir Mr. Renal effects of angiotensin-converting enzyme inhibition in congestive heart failure. Am J Cardiol 1990;66:14D-21D
  13. Heeg JE, de Jong PE, Van Der Hem GK, de Zeeuw D. Reduction of proteinuria by angiot